Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins

<table><i>Statins and recapture of the RISK pathway.</i> This modified graphic of Mensah’s work, shows how the quotient (necrosis/ischemia) is similar in rats treated for 1 or 2 weeks with methylcellulose (red bars) or atorvastatin (blue bars). This loss of myocyte-protective effect is “recaptured” significantly with the reload of atorvastatin (green bars).</table>

International Journal of Hypertension

fig4

Figure 4

Figure 4: Statins: Cardiovascular Risk Reduction in Percutaneous Coronary Intervention—Basic and Clinical Evidence of Hyperacute Use of Statins 